LIC MF Healthcare Fund Direct IDCW
Summary Info
Fund Name
: LIC Mutual Fund
Scheme Name
: LIC MF Healthcare Fund Direct IDCW
AMC
: LIC Mutual Fund
Type
: Open
Category
: Equity - Pharma
Launch Date
: 08-Feb-2019
Fund Manager
: Karan Doshi
Net Assets (Rs. cr)
: 87.59
LIC MF Healthcare Fund Direct IDCW - Nav Details
Nav Date
: 10-Dec-2025
NAV [Rs.]
: 31.8794
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
: Nil
Exit Load %
: 1.00% For exit within 12 months from the date of allotment. Nil - For exit after 12 months from the date of allotment.
LIC MF Healthcare Fund Direct IDCW- NAV Chart
LIC MF Healthcare Fund Direct IDCW- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | -1.6 | -2.56 | -1.3 | 1.7 | -3.26 | 20.87 | 13.52 | 18.63 |
| Category Avg | -1.63 | -1.5 | -1.6 | 1.24 | -1.52 | 22.35 | 16.18 | 13.93 |
| Category Best | -1.34 | -0.46 | 0.6 | 5.89 | 5.27 | 27.79 | 19.04 | 29.71 |
| Category Worst | -2.65 | -3.14 | -3.48 | -3.57 | -8.41 | 18.45 | 12.07 | -5.69 |
LIC MF Healthcare Fund Direct IDCW- Latest Dividends
No Records Found
LIC MF Healthcare Fund Direct IDCW- Investment Details
Min. Investment(Rs.)
: 5000
Increm.Investment(Rs.)
: 500
In & Out
In
InName Of The CompanyNo Of Shares
--
Out
InName Of The CompanyNo Of Shares
--
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 11.47 | 53851 | 9.86 |
| Equity | Apollo Hospitals | Healthcare Services | 5.73 | 6723 | 4.93 |
| Equity | Torrent Pharma. | Pharmaceuticals & Biotechnology | 5.68 | 13130 | 4.88 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 5.56 | 31218 | 4.78 |
| Equity | Neuland Labs. | Pharmaceuticals & Biotechnology | 4.85 | 2414 | 4.17 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 4.64 | 6158 | 3.98 |
| Equity | Fortis Health. | Healthcare Services | 4.50 | 42102 | 3.86 |
| Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 4.46 | 31301 | 3.83 |
| Equity | Piramal Pharma | Pharmaceuticals & Biotechnology | 4.32 | 198385 | 3.71 |
| Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 3.41 | 5155 | 2.93 |
| Equity | Abbott India | Pharmaceuticals & Biotechnology | 3.39 | 968 | 2.91 |
| Equity | Navin Fluo.Intl. | Chemicals & Petrochemicals | 3.20 | 4796 | 2.75 |
| Equity | OneSource Speci. | Pharmaceuticals & Biotechnology | 3.15 | 17705 | 2.71 |
| Equity | Artemis Medicare | Healthcare Services | 3.10 | 93529 | 2.66 |
| Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 2.81 | 16604 | 2.41 |
| Equity | Concord Biotech | Pharmaceuticals & Biotechnology | 2.75 | 16687 | 2.36 |
| Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 2.73 | 13351 | 2.34 |
| Equity | Glenmark Pharma. | Pharmaceuticals & Biotechnology | 2.71 | 11994 | 2.33 |
| Equity | Metropolis Healt | Healthcare Services | 2.56 | 11417 | 2.20 |
| Equity | Dr Agarwal's Hea | Healthcare Services | 2.46 | 39576 | 2.11 |
| Equity | Max Healthcare | Healthcare Services | 2.27 | 16775 | 1.95 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 2.25 | 8577 | 1.93 |
| Equity | Global Health | Healthcare Services | 2.17 | 14952 | 1.86 |
| Equity | Syngene Intl. | Healthcare Services | 2.13 | 28260 | 1.83 |
| Equity | Acutaas Chemical | Pharmaceuticals & Biotechnology | 1.77 | 8302 | 1.52 |
| Equity | Anthem Bioscienc | Pharmaceuticals & Biotechnology | 1.69 | 22961 | 1.45 |
| Equity | Vinati Organics | Chemicals & Petrochemicals | 1.61 | 8741 | 1.38 |
| Equity | Linde India | Chemicals & Petrochemicals | 1.08 | 1559 | 0.93 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
LIC Mutual Fund
Incorporation Date:
20-Apr-1994
Total Assets Managed (Cr.):
41,741.63
Trustee/s:
Mr. Pradeep Jagannath Bhi, LIC Mutual Fund Trustee P
Chairman:
NA
CEO / MD:
T.S. Ramakrishnan, Ravi Kumar Jha
CIO:
NA
President:
NA
Director/s:
Raghunandan Maluste, Vijay Sharma, Sanjay Achyutrao Muthal, Praveen Garg
Compliance Officer/s:
NA
Investor Service Officer/s:
Mr.Prashant Thakkar
Fund Manager/s:
Karan Doshi
Auditors:
S.R. Batliboi LLP
OTHER INFORMATION
Registered Office:
4th Floor, Industrial Insurance Building, Opp.Churchgate Stati Mumbai 400 020.
Contact Nos:
022-66016000
Fax:
022-22843660
Email:
Website:
